Worsening of Seizures After Asparagine Supplementation in a Child with Asparagine Synthetase Deficiency.
PMID 27268761 | DOI 10.1016/j.pediatrneurol.2016.01.024 · Pediatric neurology · 2016 · View on PubMed ↗
OBJECTIVE: Asparagine synthetase deficiency is an autosomal recessive neurometabolic disorder characterized clinically by severe congenital microcephaly, global developmental delay, intractable epilepsy, and motor impairment in the form of spastic quadriparesis. Diagnosis is confirmed by findings of low cerebral spinal fluid or plasma asparagine in addition to a mutation of the subsequently in ASNS gene. There is no documented trial of asparagine as a treatment for this disorder. PATIENT DESCRIPTION: We present a child with asparagine synthetase deficiency whose mental status improved slightly from a vegetative state to a minimally conscious state after starting asparagine supplementation. He subsequently became irritable, developed sleep disturbance, and experienced worsening seizures, requiring discontinuation of the asparagine supplements. CONCLUSIONS: Asparagine supplementation may be not effective in controlling the seizures in asparagine synthetase deficiency, and it is likely to make them worse.
Validated evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ASNS | “Diagnosis is confirmed by findings of low cerebral spinal fluid or plasma asparagine in addition to a mutation of the subsequently in ASNS gene.” | 0.98 | hgnc_dict_v1 |
| phenotype | developmental delay | “OBJECTIVE: Asparagine synthetase deficiency is an autosomal recessive neurometabolic disorder characterized clinically by severe congenital microcephaly, global developmental delay, intractable epilepsy, and motor impairment in the form of spastic quadriparesis.” | 0.98 | phenotype_alias_lexicon_v2 |
| phenotype | epilepsy | “Worsening of Seizures After Asparagine Supplementation in a Child with Asparagine Synthetase Deficiency.” | 0.93 | phenotype_alias_lexicon_v2 |